New drug shows promise in treating indolent non-Hodgkin lymphomas

A new drug, idelalisib, showed promise in a phase 2 study for treating patients with indolent non-Hodgkin lymphoma.

Fuente : http://www.eurekalert.org/pub_releases/2014-01/fhc…